Pharmafile Logo
Pharmafocus logo
Advanced Search

GSK

Showing 15 posts of 760 posts found.

gsk_china_1

China ban for corrupt pharma firms

January 2, 2014
Medical Communications, Sales and Marketing Cameron, China, GSK, Witty, bribery, lilly

News
GSK image

GSK changes sales tactics

December 17, 2013
Medical Communications, Sales and Marketing GSK, Witty, bribery, corruption, cuts, sales, transparency

GlaxoSmithKline is to remove individual staff sales targets and end doctor payments for activities that promote its products.  The UK …

News
Gsk image

GSK funnels another £200m into UK manufacturing

December 12, 2013
Manufacturing and Production, Sales and Marketing GSK, Taylor, UK, manufacturing

GlaxoSmithKline has made good on a pledge to invest in UK-based production, with £200 million ($328m) earmarked for plant upgrades …

News
gsk image

GSK launches cancer ‘consortium’

December 6, 2013
Research and Development, Sales and Marketing Cancer, GSK, octc, oncology, research

GlaxoSmithKline has formed a consortium of cancer research organisations in North America and Europe in a bid to accelerate the …

News
David Cameron image

Prime minister backs GSK in corruption row

December 4, 2013
Medical Communications, Sales and Marketing China, GSK, bribery, david cameron

Prime minister David Cameron has defended London-based pharma giant GlaxoSmithKline over its treatment in China during a visit to the …

News
gsk image

Witty goes to China

December 3, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, GSK, Witty, bribery

GlaxoSmithKline chief executive Sir Andrew Witty has embarked on a potentially delicate diplomatic mission as part of a UK trade …

News
Takeda image

GSK veteran named chief executive for Takeda

December 2, 2013
Sales and Marketing GSK, Takeda, christophe weber

Asia’s biggest drugmaker Takeda has named GlaxoSmithKline’s Christophe Weber as the leading candidate for the role of its next chief …

News
GSK image

GSK using ‘sledgehammer’ tactics on agencies

November 29, 2013
Sales and Marketing Cameron, China, GSK, horlicks, sky

GlaxoSmithKline is being accused of using ‘sledgehammer’ tactics by marketing agencies promoting its products after the firm allegedly demanded cash …

News

FDA U-turn on Avandia

November 26, 2013
Sales and Marketing Avandia, CDER, FDA, GSK, diabetes, nissen, type 2

The FDA has delivered a shock verdict that the stringent restrictions on GlaxoSmithKline’s diabetes medicine Avandia should be lifted, despite …

News
gsk image

GSK expands Montrose API plant with £25m investment

November 25, 2013
Manufacturing and Production GSK, Scotland, montrose

GlaxoSmithKline is planning to invest £25 million ($40m) at a facility in Scotland that will take on production of ingredients …

News
GSK image

GSK makes £425 million Aspen sale

November 21, 2013
Sales and Marketing GSK, Merck, South Africa, aspen

GlaxoSmithKline has raised £425 million with the sale of 28.2 million shares that it has in Africa’s biggest drugmaker as …

News
gsk image

GSK heart disease drug fails late-stage trial

November 13, 2013
Sales and Marketing GSK, darapladib, heart, statin

GSK has said its investigational chronic coronary heart disease pill darapladib has failed to meet its primary endpoint in a …

News
GSK image

GSK ‘may not face corporate charges’

November 5, 2013
Medical Communications, Sales and Marketing China, GSK, bribery

GlaxoSmithKline is unlikely to face a company-wide charge for corruption following investigations by authorities in China according to reports. The …

News
GSK logo

GSK: no Votrient Code breaches

November 4, 2013
Medical Communications, Sales and Marketing GSK, PMCPA, Pfizer

News
manufacturing_pharma_1

Pharma facility news in brief

November 4, 2013
Manufacturing and Production DSM, GSK, manufacturing

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025